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The development of atherosclerosis and the inﬂammatory response were investigated in LDLr-KO mice
on three high-fat diets (40% energy as fat) for 16 weeks: trans (TRANS), saturated (SAFA) or u-6 poly-
unsaturated (PUFA) fats. The following parameters were measured: plasma lipids, aortic root total
cholesterol (TC), lesion area (Oil Red-O), ABCA1 content and macrophage inﬁltration (immunohisto-
chemistry), collagen content (Picrosirius-red) and co-localization of ABCA1 and macrophage (confocal
microscopy) besides the plasma inﬂammatory markers (IL-6, TNF-a) and the macrophage inﬂammatory
response to lipopolysaccharide from Escherichia coli (LPS). As expected, plasma TC and TG concentrations
were lower on the PUFA diet than on TRANS or SAFA diets. Aortic intima macrophage inﬁltration, ABCA1
content, and lesion area on PUFA group were lower compared to TRANS and SAFA groups. Macrophages
and ABCA1 markers did not co-localize in the atherosclerotic plaque, suggesting that different cell types
were responsible for the ABCA1 expression in plaques. Compared to PUFA, TRANS and SAFA presented
higher collagen content and necrotic cores in atherosclerotic plaques. In the artery wall, TC was lower on
PUFA compared to TRANS group; free cholesterol was lower on PUFA compared to TRANS and SAFA;
cholesteryl ester concentration did not vary amongst the groups. Plasma TNF-a concentration on PUFA
and TRANS-fed mice was higher compared to SAFA. No difference was observed in IL-6 concentration
amongst groups. Regarding the macrophage inﬂammatory response to LPS, TRANS and PUFA presented
higher culture medium concentrations of IL-6 and TNF-a as compared to SAFA. The PUFA group showed
the lowest amount of the anti-inﬂammatory marker IL-10 compared to TRANS and SAFA groups. In
conclusion, PUFA intake prevented atherogenesis, even in a pro-inﬂammatory condition.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
It is well documented that the quantity and type of dietary fatty
acids have an important role in the development of cardiovascular
disease (CVD), especially due to their impact on plasma lipids,
lipoprotein metabolism [1] and inﬂammatory status [2].
Polyunsaturated fatty acids have beneﬁcial effects on cardio-
vascular risk [1], in part because of their hypolipidemic actions,
although the underlyingmechanisms are incompletely understood.loor, Room 3305, 01246-000,
ttenberg).
der the Elsevier OA license.According to experimental studies [3,4] and clinical trials [1] strong
association has been described between cardiovascular disease and
saturated fatty acids and more pronounced with TRANS-fat
consumption. Although saturated fatty acids have important
intracellular functions [5], their high intake raises plasma low
density lipoprotein-cholesterol (LDL-c) concentration, increasing
cardiovascular risk. Moreover, trans fatty acids also induce a pro-
atherogenic lipid proﬁle and adversely decrease high density
lipoprotein cholesterol (HDL-c) concentration [1].
The anti-atherogenic properties of HDL are, in part, attributed to
its role in reverse cholesterol transport (RCT) [6], and several
proteins and receptors involved in this process (e.g., CETP, LDLr,
apoAI) are modulated by dietary fatty acids [7e9]. The most
important transporters implicated in the cholesterol efﬂux from
Abbreviations
apoAI apolipoprotein AI
apo B apolipoprotein B
ABCA1 ATP binding cassette transporters A1
ABCG1 ATP binding cassette transporters G1
CVD cardiovascular disease
CETP cholesteryl ester transfer protein
FPLC fast protein liquid chromatography
HDL high density lipoprotein
LCAT lecithin cholesterol acyl transferase
GLC gas liquid chromatography analysis
LDLr LDL receptor
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SAFA diet enriched with saturated fatty acids
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and ABCG1 that work synergistically. ABCA1 transports phospho-
lipids (PL) and free cholesterol (FC) onto apolipoprotein AI (apoAI),
generating pre-beta HDL, whereas ABCG1 promotes cholesterol
efﬂux from macrophages onto mature HDL particles [10].
In vitro, polyunsaturated fatty acids undesirably diminish
cellular ABCA1 content and, consequently, reduce the cell choles-
terol and phospholipid apolipoprotein-mediated RCT [11,12]. Our
previous data showed that diets enriched with trans, saturated or
polyunsaturated fatty acids did not interfere with the HDL-
mediated cholesterol efﬂux in young adults [13]. These results
suggest that the underlying mechanisms involved on the pro-
atherogenic capacity of trans and saturated fatty acids seem to be
related to other steps of cholesterol transport, which deserve
investigation.
The inﬂammatory process, which contributes to the develop-
ment of atherosclerosis, is also modulated by dietary fatty acids
[14]. Macrophages and foam cells in the arterial wall secrete pro-
inﬂammatory factors such as interleukin-6 (IL-6) and tumor
necrosis factor alpha (TNF-a) that increase local inﬂammation and
contribute to lesion progression [15]. Both saturated fatty acids [16]
and trans fatty acids are known to increase the secretion of pro-
inﬂammatory markers [17] whereas polyunsaturated fatty acids,
especially the u-3 series, can do the opposite [16].
Although the many actions of different types of dietary fatty
acids on cardiovascular endpoint studies have been described, the
consequences of the simultaneous impact of the inﬂammatory
processes and plasma lipid metabolism on the development of
atherosclerosis are not yet fully elucidated.
Therefore, this studywas designed to evaluate the effects of high
fat diets enriched with trans, saturated or polyunsaturated fatty
acids on the concomitant impact of plasma lipids and the inﬂam-
matory response on the development of atherosclerotic lesions in
LDLr-KO mice.
2. Materials and methods
An expandedmethods section is provided in the Supplementary
Material.
Animals and diet: Weaned male LDLr-KO mice with a C57BL/6
background were acquired from The Jackson Laboratory (Bar
Harbor, ME, USA) and fed one of the three high-fat diets (40% of
energy as fat) enrichedwith trans (TRANS; n¼ 13), saturated (SAFA;
n ¼ 14) or polyunsaturated (PUFA; n ¼ 14) fatty acids for 16 weeks.
The diets were prepared without cholesterol addition and had
similar amounts of ﬁber, cholesterol and phytosterols. The TRANS-
fat consisted of 100% partially hydrogenated soy bean oil; the SAFA-
fat contained 11% olive oil, 5% soy bean oil and 84% palm oil; the
PUFA-fat contained 54% sunﬂower oil and 46% canola oil. Gas liquid
chromatography analyses (GLC) were provided by COGNIS Brazil(TRANS-fat) and the Faculty of Pharmaceutical Science of the
University of São Paulo (SAFA and PUFA-fat). The fatty acid
compositions of the fats used on the diets are presented in
Supplemental Table 1.
After weaning, mice were housed (12-h light/dark cycle) in
a temperature-controlled environment and allowed access to food
and water ad libitum. Mice were weighed weekly and their daily
food intake was estimated as the difference between the food
offered and the residual food in the cages. After a 16-wk period,
mice fasted for 12 h were anesthetized as described elsewhere [18].
Blood was drawn from the subclavian vein into 0.1% EDTA. All
animal experiments and care were in accordance with the Ethics
Committee of the Faculty of Medical Sciences of the University of
São Paulo (CAPPesq 670/06).
After perfusion with phosphate-buffered saline (PBS), the livers
and hearts, attached to the aortas, were excised and immediately
frozen in liquid nitrogen and stored at 80 C.
Blood sampling and lipoprotein proﬁle: Total cholesterol (TC) and
triglyceride (TG) analyses were carried out using enzymatic kits
(Roche Diagnostics, IN, USA). The plasma lipoprotein proﬁle was
determined in aliquots (100 ml) isolated from each mouse using fast
protein liquid chromatography (FPLC) as described elsewhere [18].
Plasma TNF-a and IL-6 concentrations were measured using ELISA
kits (R&D Systems, Minneapolis, MN).
Atherosclerotic lesion analysis: Five to six 4 mm-sections per
animal, 80 mm distance from each other, were stained using Oil
Red-O (ORO; SigmaeAldrich, USA) to measure atherosclerosis as
previously described [19]. Throughout this study all measurements
of images were carried out by a by an independent investigator
unfamiliar with the experimental groups, using Qwin image anal-
ysis software (Leica Imaging Systems, UK). Lesion area was
expressed as the means of the areas from analyzed sections. As
another measure of the degree of atherosclerotic lesion formation,
the whole aorta was delipidated, and TC and free cholesterol (FC)
were determined as previously described [20]. Cholesteryl ester
(CE) was calculated as the difference between the two measure-
ments. The total protein content of the residual delipidated aortic
tissue was determined using BCA kit (Pierce Ins., Rockford, IL, USA).
Collagen content in the atherosclerotic plaque: Collagen content
was measured in the aortic root, where subsequent sections were
stained with Picrosirius-red. Histomorphometry was performed
using a digital image system (Qwin image analysis software; Leica
Imaging Systems, UK), and collagen ﬁbers were identiﬁed by their
bright red (thicker ﬁbers) or yellow (thinner ﬁbers) appearance
under circularly polarized light at 40 magniﬁcation. The collagen
volume fraction (CVF, %) was expressed as the percentage of bright
area per total plaque area.
Immunohistological analyses of the atherosclerotic lesions: The
immunohistochemical (IHC) analysis for ABCA1 and the macro-
phage contents were determined in subsequent sections to those
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Fig. 1. Dietary fatty acids and the development of atherosclerosis. The atherosclerotic lesion area was determined in the aortas isolated from LDLr-KO mice fed a high fat diet for 16
weeks. Serial sections were analyzed for (A) lipid content using Oil Red-O stain; (B) macrophage inﬁltrate (anti-CD68); and (C) ABCA1 content using immunohistochemistry (anti-
ABCA1). The following parameters were quantiﬁed: (D) the atherosclerotic lesion area (n ¼ 5); (E) macrophage inﬁltrate (n ¼ 7) and (F) ABCA1 content (n ¼ 7); (G) determination of
the ABCA1: macrophage ratio of the atherosclerotic plaque; (H) aortic cholesterol content in whole aortas (n ¼ 8e13) isolated from LDLr-KO mice fed either a TRANS, SAFA or PUFA
diet for 16 weeks; *p < 0.05, **p < 0.001. Data were checked for normality and transformation was performed prior to statistical analysis. One-way ANOVA followed by the post-hoc
NewmaneKeuls Multiple Comparison Test for pair-wise comparisons was performed. Results are shown as the mean  SEM.
R.M. Machado et al. / Atherosclerosis 224 (2012) 66e7468utilized for the atherosclerosis analysis so as to ensure the same
arterial site. Brieﬂy, sections were incubated overnight (4 C) with
primary antibodies recognizing ABCA1 (rabbit anti-mouse ABCA1,
1:500; Novus Biologicals, Littleton, CO, USA) or macrophages (rat
anti-mouse CD68, 1:600; AbD Serotec, Raleigh, NC, USA), blocked
for endogenous peroxidase, incubated with secondary antibodies
conjugated with peroxidase (1:500; Abcam, MA, USA; and AbD
Serotec, Raleigh, NC, USA) and detected with a DAB substrate kit
(Vector Laboratories, CA, USA). The sections were counterstained
with Carazzi’s Hematoxylin. The stained (brown) areas were
measured utilizing Qwin image analysis software (Leica Imaging
Systems, UK). The area was expressed as the mean area of the
sections for 6e7 animals per group. A negative control was estab-
lished by omitting the primary antibodies.
For confocal microscopy, cryostat sections (4 mm) of the aortic
root were blocked and simultaneously incubated with polyclonal
rabbit anti-mouse ABCA1 (1:50, Novus Biologicals) and rat anti-
mouse CD68 (1:400, AbD Serotec) in a dark chamber for 90 min.
After washing, AlexaFluor 633-conjugated goat anti-rabbit IgGand AlexaFluor 488-conjugated donkey anti-rat (Invitrogen) were
utilized to detect ABCA1 and CD68, respectively, with a dual
immunoﬂuorescent staining. The nuclei were stained using DAPI
(SigmaeAldrich). Omission of the primary antibodies was used as
the negative control. The sections were observed with a Zeiss LSM
510 Meta confocal laser-scanning microscope using the corre-
sponding channel detector.
Peritoneal macrophage culture and stimulation: Peritoneal
macrophages were harvested by peritoneal punction, without
adding any stimulant to induce macrophage migration to the
peritoneal cavity, using sterile PBS, without EDTA, pH 7.4. Cells
were cultured on a 24-mm multiwell plate in RPMI medium
(SigmaeAldrich) containing 10% BSA (Invitrogen), penicillin and
streptomycin, and were maintained in a 5% CO2 incubator at 37 C.
After this period the cells were washed remaining only adhered
macrophages in the plaque. Cells (0.5  106/well) were stimulated
with 1 mg/mL lipopolysaccharide (LPS) from Escherichia coli (Sigma
Chemical Co., St. Louis, MO) for 24 h, and inﬂammatory factors
(TNF-a, IL-6 and IL-10) released into the culture medium were
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Fig. 2. Correlations between (A) aortic total cholesterol (TC) with lesion area, plasma TC and plasma TG concentration: the aortic TC content was positively correlated with lesion
area, plasma TC and plasma TG; (B) aortic cholesteryl ester (CE) and free cholesterol (FC) with lesion areas.
R.M. Machado et al. / Atherosclerosis 224 (2012) 66e74 69measured using a commercial ELISA kit (R&D Systems, Minneap-
olis, MN).
Statistical analysis: The data were checked for normality and
appropriate transformation were performed when necessary, prior
to statistical analysis. One-way ANOVA followed by the post-hoc
NewmaneKeuls Multiple Comparison Test for pair-wise compari-
sons was performed. The correlations were calculated using
a Spearman Test. A value of p < 0.05 was considered statistically
signiﬁcant. The data were analyzed with the GraphPad Prism
software (GraphPad Software Inc., San Diego, CA). Untransformed
data are presented in the ﬁgures, tables and text as the mean  SD
or SEM.3. Results
The dietary intake did not differ among the groups. However,
animals on the TRANS diet gained signiﬁcantly less weight during
the 16weeks period than the other groups (weight gain (g): TRANS:
17.17  1.86, SAFA: 19.26  3.24 and PUFA: 20.44  3.46; p < 0.05).3.1. Dietary fatty acids and the development of atherosclerosis
PUFA-fed mice presented the lowest amount of lipids in the
arterial wall, intima macrophage inﬁltration and ABCA1 content
compared to the SAFA and TRANS-fed mice (Fig. 1AeF).
The atherosclerotic plaque ABCA1: macrophage ratio for the
PUFA-fed mice was lower than in the TRANS-fed mice but did not
differ from the SAFA-fed mice (Fig. 1G).
Regarding the cholesterol content of the artery wall, TC was
lower with PUFA feeding than with TRANS but did not differ from
the SAFA feeding. Free cholesterol (FC) was lower in PUFA-fed mice
compared to TRANS and SAFA groups; cholesteryl ester (CE) did not
vary among the groups (Fig. 1H). The TC on the aorta was positivelycorrelatedwith lesion area (r¼ 0.56, p¼ 0.037), plasma TC (r¼ 0.47,
p ¼ 0.005), and plasma TG (r ¼ 0.52, p ¼ 0.002); lesion area was
positively correlated with CE and FC of the total aorta (r ¼ 0.73,
p ¼ 0.002 and r ¼ 0.66, p ¼ 0.01, respectively) (Fig. 2).
The liver expression of ABCA1 has a primordial role in HDL
biogenesis [21] and consequently on the prevention of athero-
sclerosis [22]. However, in the present study, the intake of diets
enriched with TRANS, SAFA or PUFA had similar effects on ABCA1
mRNA expression in the livers of the LDLr-KO mice (Supplemental
Fig. 1).3.2. Localization of ABCA1 and macrophages on the
atherosclerotic plaque
Immunohistochemical analyses suggested that ABCA1 and
macrophage expression were found in the same region of the
atherosclerotic plaque (Supplemental Fig. 2). However, the dual
immunoﬂuorescent staining (Fig. 3), in serial sections, did not show
co-localization of macrophages and ABCA1 in the plaques. This
suggested that although some expression of ABCA1 can be attrib-
uted to macrophages (CD68 positive cells), other cells types are
likely responsible for the majority of the ABCA1 expression in the
plaque.3.3. Plasma lipids and lipoprotein proﬁle
The PUFA group had the lowest plasma TC and TG concentration
compared to TRANS- and SAFA-fed mice. TRANS-fed mice devel-
oped severe hypercholesterolemia and hypertriglyceridemia
(Table 1). A greater atherogenic lipid proﬁle was observed in the
TRANS group because of the higher amount of cholesterol trans-
ported in non-HDL particles (94%), with 67% in VLDL and only 6% in
HDL (Table 1). Moreover, the TRANS diet induced a higher VLDL-TG
Fig. 3. Co-localization of macrophage and ABCA1 on the atherosclerotic plaque. Dual immunoﬂuorescent staining in serial sections did not show co-localization of ABCA1 (red) and
macrophage (green) in the atherosclerotic plaques of LDLr-KO mice fed high fat diets enriched with TRANS, SAFA or PUFA for 16 weeks. DAPI (blue) (n ¼ 3).
R.M. Machado et al. / Atherosclerosis 224 (2012) 66e7470concentration compared to the SAFA and PUFA diets and a higher
HDL-TG concentration when compared to the PUFA diet.
Plasma TC and TG concentrations were positively correlated
with the arterial macrophage inﬁltration (TC: r ¼ 0.69, p ¼ 0.0004;
TG: r ¼ 0.63, p ¼ 0.001), ABCA1 content (TC: r ¼ 0.70, p ¼ 0.0002;
TG: r¼ 0.61, p¼ 0.002) and atherosclerotic lesion area (TC: r¼ 0.77,
p ¼ 0.001; TG: r ¼ 0.86, p ¼ 0.0001). These results support the
predominant role of plasma cholesterol on the development of
atherosclerotic lesions associated with the different diets (Fig. 4).Table 1
Plasma total cholesterol (TC), triglycerides (TG) concentrations (mmol/L) are listed,
and the lipoprotein proﬁles are expressed as absolute concentration (mmol/L) and
percent distributions. Data are from LDLr-KO mice fed a TRANS, SAFA or PUFA diet
for 16 weeks.
TRANS SAFA PUFA
TC (mmol/L) 27.17  11.01a 10.39  3.29b 4.92  2.10c
TG (mmol/L) 4.17  1.40a 1.81  0.55b 1.11  0.57c
VLDL-C (mmol/L)
(%)
18.16  7.56a
(67  7)a
4.40  3.13b
(41  2)b
1.27  0.65c
(30  2)c
LDL-C (mmol/L)
(%)
7.59  3.99a
(27  7)b
4.14  1.97b
(40  13)a
2.36  1.40b
(45  16)a
HDL-C (mmol/L)
(%)
1.40  0.26a
(6  3)c
1.81  0.70a
(19  9)b
1.30  0.70a
(25  9)a
non-HDL-C (mmol/L)
(%)
25.77  11.03a
(94  3)a
8.55  3.5b
(80  9)b
3.63  1.45b
(75  9)b
VLDL-TG (mmol/L)
(%)
3.34  1.27a
(80  8)a
1.29  0.41b
(74  1)a
0.82  0.45b
(74  5)a
LDL-TG (mmol/L)
(%)
0.50  0.18b
(12  4)b
0.31  0.12b
(18  9)a
0.24  0.12b
(22  6)a
HDL-TG (mmol/L)
(%)
0.33  0.27a
(8  7)a
0.19  0.24a,b
(9  9)a
0.05  0.03b
(5  3)a
a > b > c: values within the same row with different letters indicate a signiﬁcantly
difference (p < 0$05). Cholesterol and TG percent distribution was calculated as the
area under the peaks of the FPLC proﬁles of individual plasma samples and then
converted to absolute numbers. Data are shown as the mean values  SD, n ¼ 7e9.3.4. Plasma cytokines and the inﬂammatory response
No difference was observed in IL-6 concentration amongst the
groups (Fig. 5 A). Plasma TNF-a concentration on PUFA- and
TRANS-fed mice was higher compared to SAFA-fed mice after the
16-week intake period (Fig. 5B). Regarding the macrophage
inﬂammatory response to LPS, PUFA- and TRANS-fed mice pre-
sented higher concentrations of IL-6 and TNF-a compared to SAFA,
conﬁrming the plasma ﬁndings. Compared to TRANS and SAFA
groups, the PUFA group showed the lowest amount of the anti-
inﬂammatory marker IL-10. The PUFA diet was rich in u-6 fatty
acids, which may explain the pro-inﬂammatory response observed
(Fig. 5C).
3.5. Vulnerability of the atherosclerotic plaque
TRANS- and SAFA-fed mice presented a higher amount of
collagen on the atherosclerotic plaques compared to PUFA-fed
mice, however, as expected, in this group the collagen content
was nearly undetectable, because they presented the lowest degree
of atherosclerosis. Moreover, the atherosclerotic lesions in mice fed
a TRANS or a SAFA diet had a thin ﬁbrous cap with a necrotic core
characterizing unstable plaques (Fig. 6).
4. Discussion
This study demonstrates for the ﬁrst time that the intake of
a high-fat diet enriched with u-6 polyunsaturated fatty acids pre-
vented the development of atherosclerotic lesions even in a pro
inﬂammatory condition. However, though showing a similar effect
on the inﬂammatory proﬁle, TRANS-fat led to severe atherogenesis.
These results reinforce the preponderance of plasma lipid
concentration on the atherosclerotic development [23]. The PUFA
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Fig. 4. Correlations between plasma lipid concentrations (TC and TG) and aortic root ABCA1, and macrophage inﬁltration and lesion areas. Plasma TC and TG concentrations were
positively correlated with aortic ABCA1 content, macrophage inﬁltration and, atherosclerotic lesion area.
Fig. 5. Plasma inﬂammatory proﬁle and macrophage inﬂammatory response. Peritoneal macrophages isolated from mice fed one of the three fatty diets for 16 weeks, and cultured
in RPMI medium for 48 h. After this period the cells were washed remaining only adhered macrophages in the plaque. Cells (0.5  106/well) were stimulated with 1 mg/mL
lipopolysaccharide (LPS) from Escherichia coli, for 24 h, and inﬂammatory factors (TNF-a, IL-6 and IL-10) released into the culture mediumwere measured using a commercial ELISA
kit. (A) plasma IL-6 (n ¼ 4); (B) plasma TNF-a (n ¼ 4); (C) culture medium cytokines (n ¼ 4).
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Fig. 6. Collagen content of the atherosclerotic lesion. Atherosclerotic plaque collagen content in LDLr-KO mice fed high fat diets enriched with TRANS, SAFA or PUFA fatty acids for
16 weeks was analyzed. (A) Picrosirius-red (PSR)-stained sections show the presence of a ﬁbrous cap (arrows) with depleted collagen contents and necrotic cores (*) indicative of an
unstable plaque. (B) Quantiﬁcation of the collagen volume fraction (CVF) expressed as a percentage (%) of the total plaque area (n ¼ 5).
R.M. Machado et al. / Atherosclerosis 224 (2012) 66e7472group presented a higher plasma TNF-a concentration as compared
to SAFA-fed mice, but similar to TRANS group. In accordance to
plasma ﬁndings, peritoneal macrophages from animals fed PUFA
and TRANS diets elicited higher secretions of pro-inﬂammatory
cytokines (IL-6 and TNF-a) in the medium compared to animals
on a SAFA diet. The anti-inﬂammatory mediator, IL-10, was lower in
the PUFA group compared to TRANS and SAFA groups. Evenwith an
inﬂammatory response similar to the TRANS group, the PUFA group
presented the lowest degree of atherosclerosis, arterial lipid
content, macrophage inﬁltration and ABCA1 content as compared
to TRANS and SAFA groups.
This study was performed in LDLr-KO mice which are moder-
ately hypercholesterolemic and widely used to investigate the
development of atherosclerosis. When submitted to a high fat diet,
these animals become hypercholesterolemic and develop athero-
sclerosis, even in the absence of cholesterol in the diet. In a recent
study [24], the plasma cholesterol concentration observed in LDLr-
KO mice, submitted to a high cholesterol diet was similar to our
results in TRANS fed-mice. This indicates that a high fat diet is
sufﬁcient to elevate plasma cholesterol concentration and bring
about atherosclerotic lesions. In another study [25], mice submitted
to a normal cholesterol high fat diet developed a more severe
hypercholesterolemia and larger lesions in the aortic origin cross
sections than those submitted to a normal fat high cholesterol diet.
Moreover the addition of cholesterol to the diet would blunt the
biological effect of each fatty acid on the development of
atherosclerosis.
Our data corroborate the results of epidemiological trials in
which the cardiovascular endpoint beneﬁts of polyunsaturatedfatty acids are demonstrated [26,27]. These data reinforce the
notion that some unfavorable actions of these fatty acids should be
cautiously interpreted. Regarding inﬂammation, u-6 poly-
unsaturated fatty acids are known for their pro-inﬂammatory
capacity [28]. Arachidonic acid is a substrate for eicosanoid
synthesis which is enrolled on the control of intensity and duration
of inﬂammatory responses [2]. Dietary fatty acids are incorporated
into the plasma membranes including on inﬂammatory cells, and
therefore can modulate their responses [2].
Despite the pro-inﬂammatory effect, the PUFA group presented
the lowest plasma TG and TC concentrations compared to the
TRANS and SAFA groups. Moreover, in the PUFA group 25% of total
plasma cholesterol is carried by HDL, compared with 19% on SAFA
and 6% on TRANS group, as shown in the lipid proﬁle (Table 1). This
suggests that HDL is efﬁciently delivering the cholesterol to the
liver so it can be excreted in to the bile. The improvement in the
lipid proﬁle due to PUFA administration supplanted the detri-
mental effect that inﬂammation might have caused.
Dietary fatty acids modulate the composition of cell membrane,
which resembles the fatty acids on the diet. This composition will
result in a difference in membrane ﬂuidity that can interfere on
proteins activity and cell signalization. Another effect of dietary
fatty acids is related toToll-Like Receptors (TLR). TLR 4, for example,
bounds lipopolysaccharide (LPS) and can also recognize molecules
that are not derived from bacteria, such as heat shock protein 60,
ﬁbronectin, ﬁbrinogen and certain types of fatty acids. Saturated
fatty acids are able to induce secretion of inﬂammatory markers in
a manner analogous to LPS [16]. Animals and humans can develop
endotoxin tolerance to LPS after chronic exposition [29]. Similarly,
R.M. Machado et al. / Atherosclerosis 224 (2012) 66e74 73saturated fatty acids might have stimulated TLR4 during the
feeding period, and thus peritoneal macrophages when exposed to
LPS treatment have a lower pro-inﬂammatory response. At this
time, this hypothesis cannot be supported by our data. Another
interesting point that should be further investigated is the presence
of T cells and cytokines in the plaque, which would give a better
characterization of the inﬂammatory status in the lesion. Unfor-
tunately we did not have sufﬁcient material to answer this point.
The TRANS diet induced severe hypertriglyceridemia and hyper-
cholesterolemia, probably as a result of a higher synthesis and
secretion of apoB-lipoproteins in this group. It has been shown that
trans fatty acids increase the liver lipogenic capacity [18]. Moreover,
the TRANS diet presented a pro-atherogenic proﬁle, as conﬁrmed in
other studies [1,3] with ApoB particles largely enriched with
cholesterol. Like all industrialized hydrogenated fats, the TRANS
diet was also rich in stearic acid. However, the results obtained in
this study group can be attributed to the trans fatty acid content
because in the liver, stearic fatty acid is rapidly converted to oleic
acid by the action of stearoyl-CoA desaturase 1 (SCD1) [30].
Hepatic ABCA1 content has a major impact on the development
of atherosclerosis due to its role in HDL formation; therefore, the
reduction of hepatic ABCA1 can contribute to lesion progression. It
has been demonstrated that unsaturated fatty acids lowered the
ABCA1 protein level by increasing its degradation rate, an action
that has been noted by some authors to be undesirable [11,12].
Although the biological function of this down-regulation remains
unclear, several clinical and epidemiological studies have high-
lighted the beneﬁcial effects of unsaturated fatty acid consumption
[26,27]. In the present study, liver ABCA1 mRNA expression did not
differ among the groups, suggesting that the dietary fatty acids
exerted similar modulation on the ABCA1 transcription level.
According to the present study, whichever mechanism is involved
in the increased degradation of ABCA1 by polyunsaturated fatty
acids in the in vitro studies, it does not impact in cardiovascular risk.
Awell design study, performed in mouse macrophage or human
monocyte-derived macrophage, demonstrated that elaidic acid
reduced the ABCA1-mediated cholesterol efﬂux, likewise palmitic
acid [31]. This effect was not at the ABCA1 transcription, stability or
protein level, once the ABCA1 mRNA expression and cell-surface
protein content were not altered. Moreover, the authors suggest
that these results are likely due a decrease of membrane ﬂuidity
[31]. These results help to explain why, despite the large ABCA1
content on the atherosclerotic lesion, TRANS and SAT groups were
not able to prevent the lesion progression.
Another novel ﬁnding presented here is that ABCA1 and
macrophages did not co-localize in the atherosclerotic lesion, as
clearly demonstrated by confocal microscopy. These results indi-
cate that besides macrophages, different cell types appear to be
involved in ABCA1 plaque expression. Smooth muscle cells (SMC)
migrate from the media into the intimal layer in response to
cytokines and inﬂammatory mediators, which also induce their
proliferation and change from a quiescent contractile state to an
active synthetic condition [32]. Under a cholesterol loading
condition, SMCs are converted tomacrophage-like cells and acquire
macrophage function by increasing the expression of macrophage-
related genes and by losing markers of the SMC phenotype [33].
Intima phenotype-SMCs present lower ABCA1 expression, apoAI
binding, HDL formation and also an impaired apoAI-mediated
cholesterol efﬂux [34]. We are currently investigating the contri-
bution of SMCs on the atherosclerosis development and its ABCA1
expression. Although this answer might be very important, at this
point these results would not modify our conclusions.
In the current study, the collagen content of the PUFA-fed mice
was barely discernible. The TRANS- and SAFA-fed mice developed
atheroma with a thin ﬁbrous cap shielding a necrotic core,characterizing unstable plaques that are more prone to disruption
and frequently precede thrombosis-mediated events [35].
It has been shown that ABCA1 expression in macrophages
located in the lesion area may exert a secondary role against the
progression of atherosclerosis when compared to the severity of
hyperlipidemia [22]. Our results corroborate these ﬁndings, and
additionally, we demonstrated that polyunsaturated fatty acids
diminished the ABCA1 content in the atherosclerotic lesion.
Moreover, in the PUFA group, this effect has been associated with
an inﬂammatory proﬁle and the lowest CT and TG concentrations
that culminate in atherosclerotic prevention. However, despite
a pro-inﬂammatory status similar to PUFA feeding, trans fatty acid
consumption induces severe hyperlipidemia, which had a remark-
able atherogenic impact.
In conclusion, this work reinforces the “Lipid Hypothesis” [23],
where the plasma cholesterol plays a crucial role in the develop-
ment of atherosclerosis even in the presence of an inﬂammatory
proﬁle as observed in the PUFA group.
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